Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol for Sub-Study of the ASCOT Trial
  • Published:

Protocol for Sub-study of the ASCOT Trial

An intensive phenotyping study to enable the future examination of genetic influences on hypertension-associated cardiovascular disease

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. O’Byrne S, Caulfield M Genetics of hypertension, therapeutic implications Drugs 1998 56 203–214

    Article  PubMed  Google Scholar 

  2. Gavras I, Manolis A, Gavras H Genetic epidemiology of essential hypertension J Hum Hypertens 1999 13 225–229

    Article  CAS  PubMed  Google Scholar 

  3. Galton DJ Genetic determinants of atherosclerosis-related dyslipidaemias and their clinical implications Clinica Chimica Acta 1997 257 181–197

    Article  CAS  Google Scholar 

  4. Graham IM et alPlasma homocysteine as a risk factor for vascular disease JAMA 1997 277 1775–1781

    Article  CAS  PubMed  Google Scholar 

  5. Frohlich ED et alThe heart in hypertension N Engl J Med 1992 327 998–1008

    Article  CAS  PubMed  Google Scholar 

  6. Schunkert H et alAssociation between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy N Engl J Med 1994 330 1634–1638

    Article  CAS  PubMed  Google Scholar 

  7. Prasad N et alThe relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele Q J Med 1994 87 659–662

    CAS  Google Scholar 

  8. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy Circulation 1994 90 2622–2628

    Article  CAS  PubMed  Google Scholar 

  9. Lindpainter K et alAbsence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass N Engl J Med 1996 334 1023–1028

    Article  Google Scholar 

  10. Mayet J et alLeft ventricular hypertrophy, blood pressure and ACE genotype in untreated hypertension J Hum Hypertens 1997 11 595–597

    Article  CAS  PubMed  Google Scholar 

  11. Wong KK, Summers KM, Burstow DJ, West MJ Angiotensin-converting enzyme and angiotensinogen genes in patterns of left ventricular hypertrophy and in diastolic dysfunction Clin Exp Pharmacol Physiol 1995 22 438–440

    Article  CAS  PubMed  Google Scholar 

  12. Nakayama T et alAssociation analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese Clin Genet 1997 51 26–30

    Article  CAS  PubMed  Google Scholar 

  13. Arnett DK et alAngiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: the atherosclerosis risk in communities and the NHLBI family heart studies Atherosclerosis 1998 138 111–116

    Article  CAS  PubMed  Google Scholar 

  14. Markus HS, Ruigrok Y, Ali N, Powell JF Endothelial nitric oxide synthase exon 7 polymorphism, ischaemic cerebrovascular disease, and carotid atheroma Stroke 1998 29 1908–1911

    Article  CAS  PubMed  Google Scholar 

  15. Schmidt H et alBeta-fibrinogen gene polymorphism (C148→T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study Arterioscl Thromb Vasc Biol 1998 18 487–492

    Article  CAS  PubMed  Google Scholar 

  16. Cattin L et alPolymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults Arterioscl Thromb Vasc Biol 1997 17 91–94

    Article  CAS  PubMed  Google Scholar 

  17. Castellano M et alAngiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population Circulation 1995 91 2721–2724

    Article  CAS  PubMed  Google Scholar 

  18. Kessler C et alThe apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischaemic stroke involving large-vessel disease Arterioscl Thromb Vasc Biol 1997 17 2880–2884

    Article  CAS  PubMed  Google Scholar 

  19. Levy D et alPrognostic implications of echocardiographically determined left ventricular mass in the Framingham Study N Engl J Med 1990 322 1561–1566

    Article  CAS  PubMed  Google Scholar 

  20. Salonen JT, Salonen R Ultrasonographically assessed carotid morphology and the risk of coronary heart disease Arterioscl Thromb 1992 11 1245–1249

    Article  Google Scholar 

  21. O’Leary DH et alCarotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults N Engl J Med 1999 340 14–22

    Article  PubMed  Google Scholar 

  22. Sever P, Dahlof B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, McInnes G, Mehlsen J, Nieminen M, O’Brien E, Ostergen J Rationale, design, methods and baseline demographic data of participants in the Anglo-Scandinavian Cardiac Outcomes Trial J Hypertens 2001 19 1139–1147

    Article  CAS  PubMed  Google Scholar 

  23. Pratt RE, Dzau VJ Genomics and hypertension: concepts, potentials and opportunities Hypertension 1999 33 238–247

    Article  CAS  PubMed  Google Scholar 

  24. Corvol P, Persu A, Gimenaz-Roqueplo AP, Jeunemaitre X Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel Hypertension 1999 33 1324–1331

    Article  CAS  PubMed  Google Scholar 

  25. Anonymous Proposed International Guidelines on Ethical Issues in Medical and Genetic Services (Part II). World Health Organization, Human Genetics Programme Law & the Human Genome Review 1998 9 239–251

    Google Scholar 

  26. Devereaux RB, Reichek N Echocardiographic determination of left ventricular mass in man: anatomic validation of the method Circulation 1977 55 613–618

    Article  Google Scholar 

  27. Pignoli P et alIntimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging Circulation 1986 74 1399–1406

    Article  CAS  PubMed  Google Scholar 

  28. Wendelhag I, Liang Q, Gustavsson T, Wikstrand J A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness Stroke 1997 28 2195–2202

    Article  CAS  PubMed  Google Scholar 

  29. Chapman N et alComputer algorithms for the automated measurement of retinal arteriolar diameters Br J Opthalmol 2000 (in press)

  30. Murray CD The physiological principle of minimum work 1. The vascular system and the cost of blood volume Proc Natl Acad Sci USA 1926 12 207–214

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Sherman TF On connecting large vessels to small: the meaning of Murray’s law J Gen Physiol 1981 78 431–453

    Article  CAS  PubMed  Google Scholar 

  32. Kiani MF, Hudetz AG Computer simulation of growth of anastomosing microvascular networks J Theor Biol 1991 150 547–560

    Article  CAS  PubMed  Google Scholar 

  33. Byrne A et alContinued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist inpatients undergoing coronary angioplasty Arterioscl Thromb Vasc Biol 1997 17 3224–3229

    Article  CAS  PubMed  Google Scholar 

  34. O’Brien E, Atkins N, Stassen J State of the market: a review of ambulatory blood pressure monitoring devices Hypertension 1995 26 835–842

    Article  PubMed  Google Scholar 

  35. Roman MJ et alParallel cardiac and vascular adaptation in hypertension Circulation 1992 86 1909–1918

    Article  CAS  PubMed  Google Scholar 

  36. Hughes AD et alStructural changes in the heart and carotid arteries associated with hypertension in humans J Hum Hypertens 1993 7 395–397

    CAS  PubMed  Google Scholar 

  37. Muiesan ML et alCardiac and vascular structural changes. Prevalence and relation to ambulatory blood pressure in a middle-aged general population in northern Italy: the Vobarno Study Hypertension 1996 27 1046–1052

    Article  CAS  PubMed  Google Scholar 

  38. Suurkula M et alUltrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensivepatients. Risk Intervention Study (RIS) Group Arterioscler Thromb 1994 14 1297–1304

    Article  CAS  PubMed  Google Scholar 

  39. Jennings G, Wong J Regression of left ventricular hypertrophy in hypertension: changing patterns with successive meta-analyses J Hypertens 1998 16 S29–S34

    CAS  Google Scholar 

  40. Schartl M et alRemodeling of myocardium and arteries by chronic angiotensin converting enzyme inhibition in hypertensivepatients J Hypertens 1994 12 (Suppl 4) S37–S42

    Google Scholar 

  41. Mayet J et alThe effects of antihypertensive therapy on carotid vascular structure in man Cardiovasc Res 1995 30 147–152

    Article  CAS  PubMed  Google Scholar 

  42. Stanton AV et alGreater regression of early atherosclerosis by calcium channel blockade than by angiotensin converting enzyme inhibition. (abstract) ECCR oral presentation J Hypertens 1998 32 795

    Google Scholar 

  43. Furburg CD et alEffect of lovostatin on early carotid atherosclerosis and cardiovascular events: Asymptomatic Carotid Artery Progession Study (ACAPS) Research Group Circulation 1994 90 1679–1687

    Article  Google Scholar 

  44. Crouse JR et alPravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II) Am J Cardiol 1995 75 455–459

    Article  PubMed  Google Scholar 

  45. Stanton AV et alVascular network changes in the retina with age and hypertension J Hypertens 1995 13 1724–1728

    Article  CAS  PubMed  Google Scholar 

  46. King L et alLength-diameter (L:D) ratio: a geometric parameter of the retinal vasculature diagnostic of hypertension J Hum Hypertens 1996 10 417–418

    CAS  PubMed  Google Scholar 

  47. Hutchins GM, Miner MA, Boitnott JK Vessel calibre and branch angle of human coronary artery branch points Circ Res 1976 38 572–576

    Article  CAS  PubMed  Google Scholar 

  48. FitzGerald GA, Pedersen AK, Patrono C Analysis of protacyclin and thromboxane A2 biosynthesis in cardiovascular disease Circulation 1983 67 1174–1177

    Article  CAS  PubMed  Google Scholar 

  49. Lawson J, Patrono C, Ciabattoni G, FitzGerald GA Long lived enzymatic metabolites of thromboxane B2 in the human circulation Anal Biochem 1986 155 198–205

    Article  CAS  PubMed  Google Scholar 

  50. Maclouf J, Folco G, Patrono C Eicosanoids and iso-eicosanoids: constitutive, inducible and transcellular biosynthesis in vascular disease Thromb Haemostasis 1998 79 691–705

    Article  CAS  Google Scholar 

  51. Davi G et alDiabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease Circulation 1997 96 69–75

    Article  CAS  PubMed  Google Scholar 

  52. Rokach J et alThe isoprostanes: a perspective Prostaglandins 1997 54 823–851

    Article  CAS  PubMed  Google Scholar 

  53. Kunapuli P et alProstaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways J Biolog Chem 1998 273 22442–22452

    Article  CAS  Google Scholar 

  54. Delanty N et al8-Epi PGF2a generation during coronary reperfusion: a potential quantitative marker of oxidant stress in vivo Circulation 1997 95 2492–2499

    Article  CAS  PubMed  Google Scholar 

  55. Patrono C, Fitzgerald GA Isoprostanes: potential markers of oxidant stress in atherothrombotic disease Arterioscl Thromb Vasc Biol 1997 17 2309–2315

    Article  CAS  PubMed  Google Scholar 

  56. Practico D et alLocalization of distinct F2-isoprostanes in human atherosclerotic lesions [published erratum appears in J Clin Invest 1997; 100: 2637] J Clin Invest 1997 100 2028–2034

    Article  Google Scholar 

  57. Kearney D, Fitzgerald DJ Moudlating vascular function with HMG CoA reductase inhibitors. (Editorial) J Am Coll Cardiol 2000 (in press)

  58. Notarbartolo A et alInhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia Arterioscl Thromb Vasc Biol 1995 15 247–251

    Article  CAS  PubMed  Google Scholar 

  59. Rigat B et alAn insertion/deletion polymorphism in the angiotensin 1-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 1990 86 1343–1346

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Stanton.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stanton, A., Fitzgerald, D., Hughes, A. et al. An intensive phenotyping study to enable the future examination of genetic influences on hypertension-associated cardiovascular disease. J Hum Hypertens 15 (Suppl 1), S13–S18 (2001). https://doi.org/10.1038/sj.jhh.1001089

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001089

Keywords

Search

Quick links